PET scanning and the human immunodeficiency virus-positive patient

Journal of Nuclear Medicine

Volumn 38, Issue 10, 1997, Pages 1575-1583

  O'Doherty, Michael J ^a   Barrington, Sally F ^a   Campbell, Meg ^a   Lowe, John ^a   Bradbeer, Caroline S ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Fluorodeoxyglucose; Human immunodeficiency virus; Infection; Methionine; PET; Tumor

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18; METHIONINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN CANCER; BRAIN INFECTION; BRAIN LYMPHOMA; CANCER DIAGNOSIS; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSEUDOMONAS AERUGINOSA; SUPERINFECTION; TOXOPLASMA;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRAIN; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; FEMALE; FEVER OF UNKNOWN ORIGIN; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; METHIONINE; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOXOPLASMOSIS, CEREBRAL;

EID: 0030760361     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 1992;41,RR-17.
2. World Health Organization. Acquired immunodeficiency syndrome (AIDS). 1987 revision of CDC/WHO case definition for AIDS. Wkly Epidemiol Rec 1988;63:1-7.
3. Ancelle-Park R. Expanded European AIDS case definition. Lancet 1993;341:441.
4. Bitran J, Beckerman C, Weinstein R, Bennet C, Ryo U, Pinsky S. Patterns of gallium-67 scintigraphy in patients with acquired immunodeficiency syndrome and the AIDS related complex. J Nucl Med 1987;28:1103-1106.
5. Kramer EL, Sanger JJ, Garay SM, et al. Gallium-67 scans of the chest in patients with acquired immunodeficiency syndrome. J Nucl Med 1987;28:1107-1114.
6. Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med 1994;24:128-141.
7. Tatsch K, Knesewitsch, Matuschke A, Wainryb HJ, Goebel F-D, Kirsch CM. Gallium-67 scintigraphy for evaluation of AIDS-related intestinal infections. Nucl Med Commun 1990;11:649-655.
8. Woolfenden JM, Carrasquillo JA, Larson SM, et al. Acquired immunodeficiency syndrome. Gallium-67 citrate imaging. Radiology 1987;162:383-387.
9. Palestro CJ, Zakheim DS. Gallium-67 abdominal imaging in HIV (+) and HIV (-) patients [Abstract]. J Nucl Med 1994;35:174.
10. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-648.
11. Newman J, Francis I, Kaminski M, Wahl R. FDG-PET imaging in lymphoma: correlation with CT. Radiology 1994;190:111-116.
12. Alavi JB, Alavi A, Chawluk J, et al. PET in patients with glioma. A predictor of prognosis. Cancer 1988;62:1074-1078.
13. 18F-fluorodeoxyglucose and PET. Neurology 1982;32:1323-1329.
14. Hoffman JM, Waskin HA, Schifter T, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 1993;34:567-575.
15. Ogawa T, Shishido F, Kanno I, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993;186:45-53.
16. 11C]methionine uptake in brain abscess: a PET study. J Comput Assist Tomogr 1993;17:660-661.
17. Bjurling P, Reineck R, Westerberg G, et al. Synthia, a compact radiochemistry system for automated production of radiopharmaceuticals [Abstract]. Sixth workshop on targetry and automation. Vancouver 1995.
18. 11C-methionine: improved synthesis and Q.C. Appl Radiat Isot 1995;46:173-175.
19. Bergstrom M, Litton J, Eriksson L, Bohm C, Blomquist G. Determination of object contour projections for attenuation correction in cranial positron emission tomography. J Comput Assist Tomogr 1982;6:365-372.
20. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission tomography. 1. Effect of object size. J Comput Assist Tomogr 1979;3:299-308.
21. Mirales P, Moreno S, Pereztascon M, Cosin J, Diaz MD, Bouza E. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis 1995;20:872-875.
22. Tuazon CV, Delaney MD, Simon GL, et al. Utility of gallium-67 scintigraphy and bronchial washings in the diagnosis and treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1985;132:1087-1092.
23. 99mTc-DTPA aerosol transfer in the investigation of lung infections in HIV positive patients. Respir Med 1989;83:395-401.
24. Rosso J, Guillon JM, Parrot A, et al. Technetium-99m-DTPA aerosol and gallium-67 scanning in pulmonary complications of human immunodeficiency virus infection. J Nucl Med 1992;33:81-87.
25. Meikle SR, Bailey DL, Hooper PK, et al. Simultaneous emission and transmission measurements for attenuation correction in whole-body PET. J Nucl Med 1995;36: 1680-1688.
26. Barrington SF, Carr R. Staging of Burkitt's lymphoma and response to treatment monitored by PET scanning. Clin Oncol 1995;7:334-335.
27. Ichiya Y, Kuwbara Y, Otsuka M, et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991;32:1655-1660.
28. Minn HR, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18-fluorodeoxyglucose. J Nucl Med 1988;19:1521-1525.
29. Hoekstra OS, Ossenkoppele GJ, Golding R, et al. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. J Nucl Med 1993;34:1706-1710.
30. 18F-fluorodeoxyglucose PET scanning. Radiology 1993;188:487-490.
31. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and a review of the literature. J Neurosurg 1985;65:475-495.
32. Rosenblum ML, Levy RM, Bredesen DE. Neurosurgical implications of the acquired immunodeficiency syndrome (AIDS). Clin Neurosurg 1988;22:700-706.
33. Gray F, Belec L, Keohane C, et al. Zidovudine therapy and HIV encephalitis: a 10-year neuropathological survey. AIDS 1994;8:489-493.
34. Whelan MA, Kricheff II, Handler M, et al. Acquired immunodeficiency syndrome: cerebral computed tomographic manifestations. Radiology 1993;149:477-484.
35. 18F]fluorodeoxyglucose PET. J Nucl Med 1992;33:532-536.
36. Villringer K, Jager H, Dichgans M, et al. Differential-diagnosis of CNS lesions in AIDS patients by FDG PET. J Comput Assisted Tomogr 1995;19:532-536.
37. Oriuchi N, Tamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferation activities. J Nucl Med 1993;34:2085-2089.
38. Ruiz A, Ganz WI, Post JD, et al. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. Am J Neuroradiol 1994;15:1885-1894.
39. Lorberboym M, Estok L, Machac J, et al. Rapid differential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT. J Nucl Med 1996;37:1150-1154.
40. van Gorp WG, Mandelkern MA, Gee M, et al. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia. J Neuropsychiatr 1992;4:280-287.
41. Hinkin CH, van Gorp WG, Mandelkern MA, et al. Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using PET. J Neuropsychiatr 1995;7:180-187.
42. Kim DM, Tien R, Byrum C, Ranga Rama Krishnan K. Imaging in acquired immune deficiency syndrome dementia complex (AIDS dementia complex): a review. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:349-370.